PHI test for detecting prostate cancer

Sheba Medical Center is now offering an innovative blood test designed to detect significant cancerous tumors in the prostate, delivering results in just seven business days.  

The Prostate Health Index (PHI) test is a breakthrough in prostate cancer detection, providing a more accurate evaluation of whether a biopsy is truly necessary. This simple yet advanced test, the first of its kind available in Israel, offers a clearer understanding of a patient’s overall risk of prostate cancer and is especially effective in assessing the likelihood of aggressive cancer.